THERAPEUTIC CLASS

Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor

---

We describe a type 2 diabetes patient with persistent hypoglycemia caused by sulfonylurea
misuse on top of a DPP-4 inhibitor. Hyperinsulinemia was exaggerated by dextrose administration,
but was successfully treated with octreotide. Since many patients are currently
treated with DPP-4 inhibitors, the importance of octreotide has been increasing. For
refractory sulfonylurea-induced hypoglycemia, especially when the patient is also being
given an incretin-based therapy, octreotide should be considered

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Endocrine & Metabolic system

Specific Detail Info

D i a b R e s C l i n P r a c

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment